Nalmefene
Nalmefene is a pharmaceutical drug with 20 clinical trials. Currently 1 active trials ongoing. Historical success rate of 93.8%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
4
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.8%
15 of 16 finished
6.3%
1 ended early
1
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia
Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
An Evaluation of The Absolute Bioavailability of TH104
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
Clinical Trials (20)
Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia
Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
An Evaluation of The Absolute Bioavailability of TH104
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
Pharmacokinetic Evaluation of Intranasal Nalmefene
Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia
Patient Driven Recovery With Nalmefene and Coaching
Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
Use of Selincro and Impact on Usual Practice
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study
Nalmefene in Alcohol Dependence and Borderline Personality Disorder
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
Efficacy of Nalmefene in Patients With Alcohol Dependence
Efficacy of Nalmefene in Patients With Alcohol Dependence
Nalmefene Smoking Cessation Study
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20